Company intelligence / Profile preview

Morley Medical

Leeds, England, United Kingdommorleymedical.com ↗

Ownership: Private
Development stage: Other

Overview

Morley Medical’s AI-driven PRIMO™ platform has demonstrated high accuracy (>95%) in predicting patients trending toward sepsis due to various infectious diseases. Clinical trials at top US hospitals validated its effectiveness for early detection of conditions like pneumonia, UTI, and COVID-related complications. The technology enables earlier intervention by clinicians—sometimes up to 72 hours before clinical diagnosis—improving outcomes and reducing costs[2][5].

Therapeutic areas: Infectious Diseases
Modalities: Non-pharmacological therapyDigital healthArtificial intelligence softwarePredictive analytics
Industry: Digital Health Medical Devices

Partnerships

Southern Insurance Underwriters, Inc. (SIU) – distribution partnership for The Risk MitigatorSM tool targeting hospital clients

Beyond the preview

Go deeper on Morley Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Morley Medical.

Explore the full profile